Astrana Health, Inc. (ASTH)
ASTH Stock Price Chart
Explore Astrana Health, Inc. interactive price chart. Choose custom timeframes to analyze ASTH price movements and trends.
ASTH Company Profile
Discover essential business fundamentals and corporate details for Astrana Health, Inc. (ASTH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Care Facilities
IPO Date
11 Mar 2009
Employees
1.90K
Website
https://www.astranahealth.comCEO
Brandon K. Sim
Description
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
ASTH Financial Timeline
Browse a chronological timeline of Astrana Health, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 25 Feb 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is $0.49, while revenue estimate is $952.83M.
Earnings released on 7 Aug 2025
EPS came in at $0.19 falling short of the estimated $0.36 by -47.22%, while revenue for the quarter reached $654.81M , missing expectations by -30.62%.
Earnings released on 8 May 2025
EPS came in at $0.14 falling short of the estimated $0.23 by -39.13%, while revenue for the quarter reached $620.39M , missing expectations by -1.63%.
Earnings released on 27 Feb 2025
EPS came in at -$0.15 falling short of the estimated $0.22 by -168.18%, while revenue for the quarter reached $665.21M , beating expectations by +7.77%.
Earnings released on 7 Nov 2024
EPS came in at $0.33 surpassing the estimated $0.32 by +3.13%, while revenue for the quarter reached $478.71M , missing expectations by -21.91%.
Earnings released on 7 Aug 2024
EPS came in at $0.40 surpassing the estimated $0.39 by +2.56%, while revenue for the quarter reached $486.27M , beating expectations by +10.33%.
Earnings released on 7 May 2024
EPS came in at $0.31 surpassing the estimated $0.30 by +3.33%, while revenue for the quarter reached $404.36M , missing expectations by -2.29%.
Earnings released on 27 Feb 2024
EPS came in at $0.26 surpassing the estimated $0.15 by +73.33%, while revenue for the quarter reached $353.04M , beating expectations by +3.48%.
Earnings released on 7 Nov 2023
EPS came in at $0.47 surpassing the estimated $0.27 by +74.07%, while revenue for the quarter reached $348.17M , missing expectations by -0.38%.
Earnings released on 30 Jun 2023
EPS came in at $0.28 surpassing the estimated $0.25 by +13.01%, while revenue for the quarter reached $348.21M , beating expectations by +1.82%.
Earnings released on 31 Mar 2023
EPS came in at $0.28 falling short of the estimated $0.31 by -8.80%, while revenue for the quarter reached $337.24M , beating expectations by +6.03%.
Earnings released on 30 Dec 2022
EPS came in at -$0.06 surpassing the estimated -$0.07 by +20.26%, while revenue for the quarter reached $294.21M , beating expectations by +18.94%.
Earnings released on 29 Sept 2022
EPS came in at $0.56 surpassing the estimated $0.32 by +76.77%, while revenue for the quarter reached $317.00M , beating expectations by +17.58%.
Earnings released on 29 Jun 2022
EPS came in at $0.25 surpassing the estimated $0.20 by +22.02%, while revenue for the quarter reached $269.70M , beating expectations by +10.64%.
Earnings released on 30 Mar 2022
EPS came in at $0.31 , while revenue for the quarter reached $263.26M .
Earnings released on 30 Dec 2021
EPS came in at $0.30 falling short of the estimated $0.32 by -6.25%, while revenue for the quarter reached $195.10M , missing expectations by -13.39%.
Earnings released on 29 Sept 2021
EPS came in at $0.74 , while revenue for the quarter reached $227.12M .
Earnings released on 29 Jun 2021
EPS came in at $0.28 , while revenue for the quarter reached $175.64M .
ASTH Stock Performance
Access detailed ASTH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.